Cargando…
Safety, pharmacokinetic and pharmacodynamic properties of TV-1106, a long-acting GH treatment for GH deficiency
BACKGROUND: TV-1106 (Teva Pharmaceuticals) is a genetically fused recombinant protein of human GH (hGH) and human serum albumin, in development for treatment of GH deficiency (GHD). TV-1106 is expected to have an extended duration of action compared to daily GH treatment and may enable a reduction i...
Autores principales: | Cohen-Barak, Orit, Sakov, Anat, Rasamoelisolo, Michele, Bassan, Merav, Brown, Kurt, Mendzelevski, Boaz, Spiegelstein, Ofer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4584421/ https://www.ncbi.nlm.nih.gov/pubmed/26286586 http://dx.doi.org/10.1530/EJE-15-0554 |
Ejemplares similares
-
Assessment of the Pharmacokinetics, Pharmacodynamics, and Safety of Single Doses of TV‐1106, a Long‐Acting Growth Hormone, in Healthy Japanese and Caucasian Subjects
por: Cohen‐Barak, Orit, et al.
Publicado: (2016) -
Safety, pharmacokinetics, and pharmacodynamics of TV-1380, a novel mutated butyrylcholinesterase treatment for cocaine addiction, after single and multiple intramuscular injections in healthy subjects
por: Cohen-Barak, Orit, et al.
Publicado: (2015) -
Direct and cytokine‐mediated effects of albumin‐fused growth hormone, TV‐1106, on CYP enzyme expression in human hepatocytes in vitro
por: Czerwiński, Maciej, et al.
Publicado: (2018) -
Population Pharmacokinetic Modeling and Simulation of TV‐46000: A Long‐Acting Injectable Formulation of Risperidone
por: Perlstein, Itay, et al.
Publicado: (2022) -
A long-acting GH receptor antagonist through fusion to GH binding protein
por: Wilkinson, Ian R., et al.
Publicado: (2016)